Polypeptide Multimer Synthesis via Bioorthogonal Conjugation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for protein synthesis, particularly in recombinant DNA technology, face challenges in efficiently incorporating nonnatural amino acids and forming multimeric structures with preserved biological function, such as enzyme activity, which is crucial for therapeutic and industrial applications.
Innovation Solution
The method involves introducing nonnatural amino acids like p-azido-L-phenylalanine and p-propargyloxy-L-phenylalanine into protein sequences for cell-free or in vivo synthesis, enabling bioorthogonal reactions to form multimeric structures, including polymers and virus-like particles, while strategically placing covalent bonds to maintain enzymatic activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If recombinant DNA technology is used to produce proteins in cellular environments, then protein production is achieved, but nonnatural amino acids cannot be incorporated and multimeric structures cannot be formed
Solution Approach 1:
The invention segments the protein synthesis process into two distinct stages: (1) cell-free synthesis of individual polypeptide subunits containing nonnatural amino acids, and (2) in vitro conjugation of these subunits into multimeric structures. This segmentation allows each stage to be optimized independently, avoiding the limitations of traditional cellular-based approaches while maintaining manufacturing feasibility.
Solution Approach 2:
The invention introduces nonnatural amino acids with reactive groups (such as azides or alkynes) as intermediaries that enable bioorthogonal reactions between polypeptide subunits. These reactive groups serve as molecular mediators that facilitate the formation of covalent bonds between subunits, creating multimeric structures without requiring cellular machinery.
2Adaptability or versatility
If cell-free protein synthesis is used to incorporate nonnatural amino acids, then nonnatural amino acids can be incorporated, but the process requires multiple steps and purification
Solution Approach 1:
The invention merges the conjugation of multiple polypeptide subunits into a single step by utilizing bioorthogonal reactions that proceed in one pot. Multiple subunits containing different nonnatural amino acids are combined in a single reaction vessel, and the bioorthogonal chemistry automatically directs the formation of correct multimeric structures without requiring sequential assembly or intermediate purification steps.
3Stability of the object's composition
If covalent bonds are introduced to form multimeric structures, then structural stability is improved, but biological activity may be lost
Solution Approach 1:
The invention applies local quality by introducing reactive nonnatural amino acids at specific locations on polypeptide subunits rather than uniformly throughout the structure. The positioning of reactive groups is strategically selected to enable conjugation at locations that do not interfere with the catalytic active sites or critical functional regions, thereby maintaining biological activity while achieving structural stability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the high-yield production of multimeric structures with retained biological activity, enhancing substrate conversion and stability, and enables the creation of novel biomaterials and scaffolds with improved properties.
Implementation Method 1
The nonnatural amino acids are selected to be reactive with each other in a bioorthogonal reaction. p-azido-L-phenylalanine (pAzF) and p-propargyloxy-L-phenylalanine (pPaF) are of particular interest for azide-alkyne cycloaddition.
Data Source
AI summary
Methods are provided for a one step synthesis of polypeptide polymers or co-polymers. The polymers or co-polymers can be linear or branched. In the methods of the invention, the coding sequence for the polypeptide(s) to be polymerized is altered by introducing one or more codons for an nonnatural amino acid, which coding sequence is then utilized to produce the cognate polypeptide. The nonnatural amino acids are selected to be reactive with each other in a bioorthogonal reaction, and are combined in a conjugation reaction with the desired components of the polymer.